Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...
The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure
The five-phase validation process involved 854 patients with cancer and 15 oncology specialists. The initial pool of 370 overlapping items for breast, lung, and colorectal cancer was generated by open ...
Quality of Life Research, Vol. 23, No. 3 (April, 2014), pp. 815-824 (10 pages) Purpose To develop and validate a new functional assessment of chronic illness therapy (FACIT) measure of satisfaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback